BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1563453)

  • 1. Long-term results of corticosteroid therapy in patients with myasthenia gravis.
    Evoli A; Batocchi AP; Palmisani MT; Lo Monaco M; Tonali P
    Eur Neurol; 1992; 32(1):37-43. PubMed ID: 1563453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of steroid treatment in myasthenia gravis: a retrospective study.
    Cosi V; Citterio A; Lombardi M; Piccolo G; Romani A; Erbetta A
    Acta Neurol Scand; 1991 Jul; 84(1):33-9. PubMed ID: 1927259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term prednisone followed by thymectomy in myasthenia gravis.
    Mann JD; Johns TR; Campa JF; Muller WH
    Ann N Y Acad Sci; 1976; 274():608-22. PubMed ID: 1066998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term administration of corticosteroids in myasthenia gravis.
    Mann JD; Johns TR; Campa JF
    Neurology; 1976 Aug; 26(8):729-40. PubMed ID: 821005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical outcome after extended thymectomy combined postoperative high-dose steroid therapy for juvenile myasthenia gravis.
    Kanzaki M; Obara T; Sasano S; Hikawa Y; Onuki T
    Ann Thorac Cardiovasc Surg; 2008 Apr; 14(2):119-22. PubMed ID: 18414352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients.
    Pascuzzi RM; Coslett HB; Johns TR
    Ann Neurol; 1984 Mar; 15(3):291-8. PubMed ID: 6721451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does perioperative high-dose prednisolone have clinical benefits for generalized myasthenia gravis?
    Sekine Y; Kawaguchi N; Hamada C; Sekiguchi H; Yasufuku K; Iyoda A; Shibuya K; Fujisawa T
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):908-13. PubMed ID: 16675232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin and corticosteroids in generalized myasthenia gravis: comparative studies and role in management.
    Brunner NG; Berger CL; Namba T; Grob D
    Ann N Y Acad Sci; 1976; 274():577-95. PubMed ID: 183590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing the relapse risk at steroid dose reduction in myasthenia gravis.
    Scherpbier HJ; Oosterhuis HJ
    Clin Neurol Neurosurg; 1987; 89(3):145-50. PubMed ID: 3665287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment of myasthenia gravis with alternate-day prednisone. Report on 15 patients.
    Pinelli P; Tonali P; Scoppetta C
    Eur Neurol; 1974; 12(3):129-41. PubMed ID: 4426321
    [No Abstract]   [Full Text] [Related]  

  • 11. Thymectomy in the treatment of ocular myasthenia gravis.
    Roberts PF; Venuta F; Rendina E; De Giacomo T; Coloni GF; Follette DM; Richman DP; Benfield JR
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):562-8. PubMed ID: 11547310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disseminated thymoma and myasthenia gravis: dramatic response to prednisone.
    Taylor R; Tandan R; Roberts J; DiCostanzo DP; Sharma K; Fries T
    Ann Neurol; 1989 Feb; 25(2):208-9. PubMed ID: 2919872
    [No Abstract]   [Full Text] [Related]  

  • 13. Juvenile myasthenia gravis and thymectomy: report of ten cases.
    de Assis JL; Marchiori PE; Zambon AA; Scaff M
    Rev Hosp Clin Fac Med Sao Paulo; 1992; 47(5):234-6. PubMed ID: 1340608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis.
    Ponseti JM; Gamez J; Vilallonga R; Ruiz C; Azem J; López-Cano M; Armengol M
    Eur J Cardiothorac Surg; 2008 Nov; 34(5):1062-7. PubMed ID: 18760934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgical therapy of myasthenia gravis and thymoma].
    Bertram P; Treutner KH; Winkeltau G; Schumpelick V
    Chirurg; 1993 Oct; 64(10):796-801. PubMed ID: 8269744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of thymectomy on late-onset myasthenia gravis without thymoma.
    Kawaguchi N; Kuwabara S; Nemoto Y; Fukutake T; Arimura K; Osame M; Hattori T
    Clin Neurol Neurosurg; 2007 Dec; 109(10):858-61. PubMed ID: 17904281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A relapsing-remitting type of ocular myasthenia gravis without typical muscle fatiguability.
    Werner P; Kiechl S; Thaler C; Willeit J; Poewe W; Baldissera I
    J Neurol Neurosurg Psychiatry; 2002 Aug; 73(2):205. PubMed ID: 12122188
    [No Abstract]   [Full Text] [Related]  

  • 18. [Trans-sternal thymectomy in myasthenia gravis and thymoma].
    Mönig SP; Türler A; Raab M
    Zentralbl Chir; 1995; 120(12):963-8. PubMed ID: 8585347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with starting tacrolimus postoperatively after transsternal extended thymectomy in patients with myasthenia gravis.
    Ponseti JM; Azem J; Fort JM; López-Cano M; Vilallonga R; Gamez J; Armengol M
    Curr Med Res Opin; 2006 May; 22(5):885-95. PubMed ID: 16709310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-thymectomy combined treatment of prednisone and tacrolimus versus prednisone alone for consolidation of complete stable remission in patients with myasthenia gravis: a non-randomized, non-controlled study.
    Ponseti JM; Gamez J; Azem J; Fort JM; López-Cano M; Vilallonga R; Buera M; Armengol M
    Curr Med Res Opin; 2007 Jun; 23(6):1269-78. PubMed ID: 17559724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.